CD274 and non-small cell lung carcinoma: In non-SQ NSCLC patients, PD-L1 expression was measurable in 40/76 patients and was classified as <1, ≥1–<50 and ≥50% in 13 (32.5%), 20 (50.0%) and 7 (17.5%) patients, respectively.